CLINICAL CHARACTERIZATION OF RESPONDERS TO ORAL SULFONYLUREA AGENTS IN TYPE-II DIABETIC-PATIENTS

被引：0
|
作者：
OSEI, K [1 ]
机构：
[1] OHIO STATE UNIV,DEPT MED,COLUMBUS,OH 43210
来源：
CLINICAL RESEARCH | 1986年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A431 / A431
页数：1
相关论文
共 50 条
  • [31] SERUM GLYCATED LIPOPROTEINS IN TYPE-II DIABETIC-PATIENTS WITH AND WITHOUT COMPLICATIONS
    YEGIN, A
    OZBEN, T
    ANNALS OF CLINICAL BIOCHEMISTRY, 1995, 32 : 459 - 463
  • [32] THE NUTRITIONAL-STATUS OF AMBULATORY ELDERLY TYPE-II DIABETIC-PATIENTS
    MOORADIAN, AD
    KALIS, J
    NUGENT, CA
    AGE, 1990, 13 (04) : 87 - 89
  • [33] LIPOPROTEIN ABNORMALITIES IN WELL-TREATED TYPE-II DIABETIC-PATIENTS
    MANZATO, E
    ZAMBON, A
    LAPOLLA, A
    ZAMBON, S
    BRAGHETTO, L
    CREPALDI, G
    FEDELE, D
    DIABETES CARE, 1993, 16 (02) : 469 - 475
  • [34] SURVIVAL, OF BLACK TYPE-II DIABETIC-PATIENTS (DP) ON HEMODIALYSIS (HD)
    WOREDEKAL, Y
    LUNDIN, AP
    JOSEPH, N
    PAUL, H
    DOSUNMU, B
    DANIELS, I
    FRIEDMAN, EA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 568 - 568
  • [35] NITRENDIPINE IN THE TREATMENT OF ARTERIAL-HYPERTENSION IN TYPE-II DIABETIC-PATIENTS
    MALACCO, E
    GNEMMI, AE
    MAGENTA, M
    NOIA, E
    SARTINI, C
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1991, 50 (03): : 348 - 355
  • [36] NEPHROPROTECTIVE EFFECTS OF NITRENDIPINE IN HYPERTENSIVE TYPE-I AND TYPE-II DIABETIC-PATIENTS
    BRETZEL, RG
    BOLLEN, CC
    MAESER, E
    FEDERLIN, KF
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1993, 21 (06) : 53 - 64
  • [37] CLINICAL EFFICACY AND TOLERANCE OF ACARBOSE IN THE TREATMENT OF NON-INSULIN-DEPENDENT DIABETIC-PATIENTS (TYPE-II)
    DELEIVA, A
    PINON, F
    TEBAR, J
    ESCOBARJIMENEZ, F
    DELACALLE, H
    HERRERAPOMBO, JL
    SOLER, J
    PALLARDO, LF
    GIL, E
    GUARDIOLA, E
    ARROYO, A
    INIGO, P
    CAMPOS, MM
    FERNANDEZSOTO, M
    GONZALEZ, A
    MUNOZTORRES, M
    LIGORRIA, C
    MEDICINA CLINICA, 1993, 100 (10): : 368 - 371
  • [38] ELEVATED PLASMA PRORENIN MAY BE A MARKER OF NEPHROPATHY IN TYPE-II DIABETIC-PATIENTS
    ANDERSON, RW
    SHAW, S
    HSUEH, WA
    CLINICAL RESEARCH, 1991, 39 (02): : A455 - A455
  • [39] LIPOPROTEIN(A) LEVELS IN TYPE-II DIABETIC-PATIENTS ARE NOT INFLUENCED BY METABOLIC CONTROL OR BY MICROALBUMINURIA
    ZAMBON, S
    BALDOENZI, G
    BAIOCCHI, M
    NOSADINI, R
    MANZATO, E
    CREPALDI, G
    DIABETES CARE, 1994, 17 (12) : 1548 - 1549
  • [40] EARLY-ONSET OF PHARMACODYNAMIC EFFECTS OF GLIMEPIRIDE IN TYPE-II DIABETIC-PATIENTS
    WERNICKEPANTEN, K
    HAUPT, E
    PFEIFFER, C
    MAYER, A
    DRAEGER, KE
    DIABETOLOGIA, 1994, 37 : A163 - A163
12345